
Oncolytics Biotech, Inc (ONCY) is destined for greater heights as its last quarter sales were 0 K
On Tuesday, Oncolytics Biotech, Inc (NASDAQ: ONCY) was 10.58% up from the session before settling in for the closing price of $1.04. A 52-week range
On Tuesday, Oncolytics Biotech, Inc (NASDAQ: ONCY) was 10.58% up from the session before settling in for the closing price of $1.04. A 52-week range
On Tuesday, Oncolytics Biotech, Inc (NASDAQ: ONCY) was 4.17% up from the session before settling in for the closing price of $0.99. A 52-week range
Oncolytics Biotech, Inc (NASDAQ: ONCY) kicked off on Friday, up 14.86% from the previous trading day, before settling in for the closing price of $0.94.
Witnessing the stock’s movement on the chart, on Wednesday, Oncolytics Biotech, Inc (NASDAQ: ONCY) set off with pace as it heaved 18.56% to $1.02, before
On Friday, Oncolytics Biotech, Inc (NASDAQ: ONCY) was -6.20% drop from the session before settling in for the closing price of $0.92. A 52-week range
On Monday, Oncolytics Biotech, Inc (NASDAQ: ONCY) opened lower -10.80% from the last session, before settling in for the closing price of $0.99. Price fluctuations
As on Wednesday, Oncolytics Biotech, Inc (NASDAQ: ONCY) started slowly as it slid -4.03% to $1.19, before settling in for the price of $1.24 at
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.